Clinical trial
ANG-001 Pelvic Mass Training Study: Evaluation of Multiple Circulating Tumor Cell-derived RNA Markers to Estimate Risk of Ovarian Cancer in Patients Presenting With a Pelvic Mass.
NCT02785731 is registered in ClinicalTrials.gov with Angle plc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ANG-001 Pelvic Mass Training Study: Evaluation of Multiple Circulating Tumor Cell-derived RNA Markers to Estimate Risk of Ovarian Cancer in Patients Presenting With a Pelvic Mass.
- Lead sponsor
- Angle plc
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 14, 2016
- Completion date
- July 31, 2018
- Enrollment
- 204 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.